# The Effect and Safety of Different Doses of Atropine on Myopic Progression of Highly Myopic Children: Multi-centered Randomized Clinical Trial

> **NCT04699357** · NA · COMPLETED · sponsor: **Shanghai Eye Disease Prevention and Treatment Center** · enrollment: 219 (actual)

## Conditions studied

- High Myopia

## Interventions

- **DRUG:** Atropine

## Key facts

- **NCT ID:** NCT04699357
- **Lead sponsor:** Shanghai Eye Disease Prevention and Treatment Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-04
- **Primary completion:** 2024-08-21
- **Final completion:** 2024-09-01
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04699357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04699357, "The Effect and Safety of Different Doses of Atropine on Myopic Progression of Highly Myopic Children: Multi-centered Randomized Clinical Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04699357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*